Op het forum van Phoenix Rising is de posterpresentatie
van prof. de Meirleir en kollega's tijdens de eerste internationale XMRV-workshop gepubliceerd.
Alhoewel de studie zeer klein was (16 XMRV-kweekkultuur-positieve ME/CVS-patiënten),
bevestigen de resultaten van deze studies alle kenmerkende biologische afwijkingen
(inflammatie, immuundysfunctie/-suppressie, lekke darm en translokatie van darmbakteria).
Abnormaliteiten die al jaren door "vermoeidheidsdeskundigen" ontkend of genegeerd worden.
De voornaamste bevindingen van de Meirleir, Metzger, Roelant en Frémont in een notedop:
Voor de PDF-versie van de posterpresentatie, klik op onderstaande afbeelding:
Is the mechanism of systemic immune activation in XMRV positive CFS patients similar to that observed in HIV?
Kenny De Meirleir M.D., PhD, Vrije Universiteit Brussel, Brussel, Belgium;
Marc Frémont, PhD;
K. Metzger, MS;
C. Roelant, PhD, RED Laboratories NV, Zellik, Belgium
BACKGROUND
Chronic activation of the immune system
is a hallmark of progressive HIV infection and
is a better predictor of disease outcome than plasma viral load.
Brenchley et al showed that
circulating microbial products
were a cause of HIV-related immune activation,
which they called microbial translocation.
We have previously shown that
Chronic Fatigue Syndrome (CFS) patients suffer
from gastrointestinal dysbiosis 2 and
from immune dysfunctions 3.
Because of the recent discovery of
presence of an infectious retrovirus, XMRV
in blood cells of patients with chronic fatigue syndrome
by Lombardi et al 4,
we wanted to test the hypothesis that
the pathophysiology of the systemic immune activation
in XMRV positive CFS patients
could be similar to the one observed in HIV.
PATIENTS AND METHODS
Sixteen CFS patients fulfilling the Canadian criteria 5
who were found positive for XMRV by co-culture technique 4
(a sensitive cell culture assay for detection of XMRV)
were included in the study.
Because of the low number of subjects studied
we chose to use reference data from a large control population
which were collected earlier.
Immunophenotyping was performed in the laboratory of clinical hematology
(University Hospital Brussel, Belgium)
using standard flow cytometry:
- T cells (CD3+, CD4+, CD8+, CD4/CD8, CD3+CD16CD56+),
- B cells (CD19+),
- NK cells (CD3-CD16CD56+),
- other (CD2+, CD2+CD25+, CD25+, CD3+HLADR+, CD19+CD5+, CD57+).
Elastase activity was measured in monocytes and lymphocytes
using an enzymatic colorimetric assay EnzChek® Elastase Assay kit E-12056
(Molecular Probes, OR, USA).
C4a: an elisa technique was used using Becton Dickinson OptElA human C4a elisa kit.
lgG3: nephelometry in serum.
Cytokines and sCD14: serum level measurement
using Becton Dickinson Cytometric Bead Assay system.
Perform: mRNA level measured by real-time PCR,
using gene expression assay reagents from Applied Biosystems.
Stool IgA: sent to Diagnos-Techs (Seattle, Washington, and analysed in their labs).
The descriptive statistics for the different parameters are presented in a table on this poster.
STATISTICAL ANALYSIS
Parameters
|
Normal Range
|
Reference value
|
Sign. p
|
|
|
|
|
CD3+
|
982-2508
|
2236
|
0.040
|
CD57+
|
60-360
|
210
|
0.001
|
C4a
|
20-1400
|
710
|
<0.001
|
Elastase
|
0- 150
|
75
|
0.032
|
Stool IgA
|
400-800
|
600
|
<0.001
|
IgG3
|
>20
|
40
|
<0.001
|
sCD14
|
2800-5000
|
3900
|
<0.001
|
IL10
|
0-5
|
2.5
|
0.001
|
MCP1
|
0-165
|
82.5
|
0.016
|
MIP-beta
|
0-155
|
77.5
|
0.031
|
IL8
|
0-10
|
5
|
0.021
|
CD4+
|
495-1652
|
1074
|
NS
|
CD8+
|
376-1119
|
748
|
NS
|
CD4/CD8
|
0.9-2.0
|
1.45
|
NS
|
CD16CD56
|
20-113
|
66.5
|
NS
|
CD19+
|
111-401
|
265
|
NS
|
CD3-CD56
|
64437
|
250.5
|
NS
|
CD2+
|
1158-2680
|
1919
|
NS
|
CD25+
|
142-493
|
317.5
|
NS
|
HLADR+
|
28-197
|
112.5
|
NS
|
CD19CD5
|
dec-73
|
42.5
|
NS
|
CD5+
|
1367-2971
|
2169
|
NS
|
Perforin
|
250-750
|
500
|
NS
|
WBC
|
4000-10000
|
7000
|
NS
|
IL12
|
0-5
|
2.5
|
NS
|
IL1-beta
|
0-3
|
1.5
|
NS
|
IL6
|
0-5
|
2.5
|
NS
|
TGF-beta
|
0-290
|
145
|
NS
|
AIpha-TNF
|
0-6
|
3
|
NS
|
A one sided t-test was used
to test the hypothesis that
the mean value of the XMRV group
is significantly different from the middle of the normal range
(representing normal population).
A two-sided test was used
when abnormal values can occur at both sides of the normal range,
otherwise a one-sided test was used.
The significance level was set at 0.05.
The statistical analysis was performed by Prof. D. Coomans
at the department of medical statistics of
the faculty of medicine and pharmacy at the Vrije Universiteit Brussel.
RESULTS
The number of CD3+ T cells and CD57+ lymphocytes
was significantly lower
compared to the reference values.
C4a and elastase activity
were significantly higher
in the XMRV positive CFS population.
Soluble CD14
which codes for LPS in the plasma
was significantly higher
at p < 0.001 compared to the reference population.
XMRV positive CFS patients
had significantly higher
serum IL-10, MCP-1 , MIP-1 beta and IL-8 levels.
Serum levels of other cytokines
(IL-12, IL-1 beta, IL-6, TGF-beta and alpha-TNF)
were not statistically different
compared to the reference values.
Other lymphocyte subsets
showed
no difference from the reference in the XMRV positive patients.
Stool lgA and lgG3
were statistically lower
in the XMRV positive patients.
CONCLUSION
The results of this preliminary study in a limited number of subjects
show that XMRV positive CFS patients have
lower than normal levels of lymphocytes and low numbers of CD57+ lymphocyte subtype
as in HIV.
The absolute numbers of CD4+ and CD8+T cells
were not statistically different from the reference values,
but expanding this study to a larger number of patients is necessary
to make solid statements in this regard.
XMRV-positive CFS patients have an activated innate immune system
(elastase activity, increased C4a)
which could be related to microbial translocation
as their sCD14 is significantly higher than expected;
sCD14 strongly correlates with plasma LPS 1.
Low stool IgA (in some of these 16 patients it was undetectable)
also points towards a dysfunctional mucosa-associated lymphomal tissue (MALT)
in XMRV-positive CFS patients.
Furthermore we found that
these patients as a group have lower than normal lgG3 serum levels.
The cytokines IL-8, IL-10, MCP-1 and MIP-1beta are increased
and might constitute a biological signature for the viral infection.
These observations and others
(unpublished data on serum levels of LPS in CFS patients)
provide evidence for
microbial translocation
being part of
the pathophysiology
of XMRV positive patients.
REFERENCES
- Brenchley J.M., et al.
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
Nature Medicine 12 (12): 1365-1371, 2006.
- Fremont M., et al.
Detection of herpes-viruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients.
In Vivo, 23: 209-214, 2009.
- Meeus M., et al.
Unraveling Intracellular Immune Dysfunctions in Chronic Fatigue Syndrome:
Interactions between Protein Kinase R Activity, RNase-L cleavage and Elastase Activity and their Clinical Relevance.
In Vivo 22: 115-122, 2008.
- Lombardi V., et al.
Detection of an infectious retrovirus, XMRV, in blood cells of patients with Chronic Fatigue Syndrome.
Science 326: 585-589, 2009.
- Carruthers B, et al.
Myalgic encephalomyelitis / chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols.
J. Chronic Fatigue Syndrome 11: 1-12, 2003.
Met dank aan Terry die mij opmerkzaam maakte op het dokument.
|